APA

Xue G., Kohler R., Tang F., Hynx D., Wang Y., Orso F., Prêtre V., Ritschard R., Hirschmann P., Cron P., Roloff T., Dummer R., Mandalà M., Bichet S., Genoud C., Meyer A. G., Muraro M. G., Spagnoli G. C., Taverna D., Rüegg C., Merghoub T., Massi D., Tang H., Levesque M. P., Dirnhofer S., Zippelius A., Hemmings B. A. & Wicki A. (2017). mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition. : Oncotarget.

Chicago

Xue Gongda, Kohler Reto, Tang Fengyuan, Hynx Debby, Wang Yuhua, Orso Francesca, Prêtre Vincent, Ritschard Reto, Hirschmann Petra, Cron Peter, Roloff Tim, Dummer Reinhard, Mandalà Mario, Bichet Sandrine, Genoud Christel, Meyer Alexandra G, Muraro Manuele G, Spagnoli Giulio C, Taverna Daniela, Rüegg Curzio, Merghoub Taha, Massi Daniela, Tang Huifang, Levesque Mitchell P, Dirnhofer Stephan, Zippelius Alfred, Hemmings Brian A and Wicki Andreas. 2017. mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition. : Oncotarget.

Harvard

Xue G., Kohler R., Tang F., Hynx D., Wang Y., Orso F., Prêtre V., Ritschard R., Hirschmann P., Cron P., Roloff T., Dummer R., Mandalà M., Bichet S., Genoud C., Meyer A. G., Muraro M. G., Spagnoli G. C., Taverna D., Rüegg C., Merghoub T., Massi D., Tang H., Levesque M. P., Dirnhofer S., Zippelius A., Hemmings B. A. and Wicki A. (2017). mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition. : Oncotarget.

MLA

Xue Gongda, Kohler Reto, Tang Fengyuan, Hynx Debby, Wang Yuhua, Orso Francesca, Prêtre Vincent, Ritschard Reto, Hirschmann Petra, Cron Peter, Roloff Tim, Dummer Reinhard, Mandalà Mario, Bichet Sandrine, Genoud Christel, Meyer Alexandra G, Muraro Manuele G, Spagnoli Giulio C, Taverna Daniela, Rüegg Curzio, Merghoub Taha, Massi Daniela, Tang Huifang, Levesque Mitchell P, Dirnhofer Stephan, Zippelius Alfred, Hemmings Brian A and Wicki Andreas. mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition. : Oncotarget. 2017.